Circulating blood microbiome biomarkers as liquid biopsy in breast cancer
Circulating tumor material can already be used to help in cancer management, but host–microbiota interactions may add complementary value. This study evaluated a “liquid microbiopsy”, combining cell-free microbial DNA (cf-mbDNA) with host biomarkers of microbial translocation/permeability (LBP, sCD14, I-FABP), to...